Ardelyx share price logo

Ardelyx

NASDAQ: ARDX

Small Cap

$3.38

-0.01

(-0.15%)

as on

Ardelyx Stock Performance

as on September 18, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $3.34
    $3.50
    downward going graph

    1.18%

    Downside

    3.55%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.34
    $8.40
    downward going graph

    1.18%

    Downside

    148.52%

    Upside

    downward going graph

Ardelyx share price movements today

Previous Close
$3.39
Open
$3.42
Volume
3.7M
Market Cap
$877.8M
Day's Low - High
$3.34 - $3.50
52 Week Low - High
$3.34 - $8.40

Ardelyx Historical Returns

1 Month Return
-16.5 %
3 Month Return
-41.95 %
1 Year Return
-45.23 %
3 Year Return
-25.49 %
5 Year Return
+ 158.78 %

Ardelyx Stock Fundamentals & Key Indicators

Check Ardelyx market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$877.8M

EPS (TTM)

-0.2257

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-15.06

Industry PE ratio

-6.71

PEG Ratio

6.142103355218094

EBITDA

-23.8M

Revenue (TTM)

450.9M

Profit Margin

93.96%

Return On Equity TTM

-36.00%

Ardelyx Stock Valuation

Track how Ardelyx P/E has moved over time to understand its valuation trends.

Ardelyx in the last 5 years

  • Overview

  • Trends

Lowest (-29.82x)

December 31, 2024

Today (-22.42x)

December 31, 2025

Industry (-6.71x)

December 31, 2025

Highest (-0.72x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: -22.42x

Ardelyx vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ardelyx with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Ardelyx image
Ardelyx
BUY$877.8M158.78%-15.0693.96%0.00%
Revolution Medicines image
Revolution Medicines
BUY$43.9B527.35%NA0.00%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
BUY$130.4B172.58%29.7186.04%0.00%
Moderna image
Moderna
BUY$57.4B-66.14%-18.02-12.57%0.00%
Regeneron image
Regeneron
BUY$81.7B18.83%18.4884.86%0.48%

Stock Returns calculator for Ardelyx Stock including INR - Dollar returns

The Ardelyx stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Ardelyx investment value today

Current value as on today

₹59,698

Returns

-₹40,302

(-40.3%)

Returns from Ardelyx Stock

-₹45,396 (-45.4%)

Dollar Impact

₹5,094 (+5.09%)

Analyst Recommendation on Ardelyx Stock

Based on 8 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 8 analysts, 100% of analysts recommend a 'BUY' rating for Ardelyx. Average target price of $12.9

Ardelyx Share Price Target

Get share price movements and forecasts by analysts on Ardelyx.

What analysts predicted

73.8%UPSIDE

Target Price

$12.9

Current Price

$3.38

Analyzed by

8 Analysts

Target

$12.90

Ardelyx target price $12.9, a slight upside of 73.8% compared to current price of $3.38. According to 8 analysts rating.

Indian Investors' Interest in Ardelyx Stock

Search interest for Ardelyx Stock has decreased by -23% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-23% versus previous 30 day period

Ardelyx Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
46
73
98
116
74
97
110
125
94
120
Gross Profit
38
63
82
97
61
84
105
113
89
115
Operating Income
-24
-13
2
8
-36
-14
4
5
-32
-12
EBITDA
-21
-10
5
11
-33
-11
8
8
-29
-10
Interest Expense
4
4
5
5
6
6
7
7
6
4
Depreciation
0
0
0
0
0
0
0
0
0
1
Income Before Tax
-26
-16
0
4
-40
-19
0
0
-37
-16
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-26
-16
0
4
-41
-19
0
0
-37
-16
Net Profit Margin
83.57%
86.34%
83.99%
84.27%
82.59%
86.65%
95.57%
90.60%
94.91%
95.24%

Ardelyx Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
42
2
5
7
10
52
124
333
407
Gross Profit
33
2
4
7
9
48
106
283
364
Operating Income
-65
-90
-91
-90
-154
-63
-63
-27
-40
EBITDA
-60
-85
-84
-85
-150
-60
-55
-16
-29
Interest Expense
-
3
5
5
4
5
8
20
28
Depreciation
2
2
4
3
2
1
1
2
3
Income Before Tax
-63
-91
-94
-94
-158
-67
-65
-38
-60
Income Tax Expense
1
0
0
0
0
0
0
0
0
Net Income
-64
-91
-94
-94
-158
-67
-66
-39
-61
Net Profit Margin
80.00%
82.13%
88.64%
98.08%
90.10%
92.11%
85.70%
84.85%
89.54%

Ardelyx Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-26
-16
0
4
-41
-19
0
0
-37
-16
Operating Cash Flow
-35
-19
0
9
-38
-25
0
20
-32
-6
Investing Cash Flow
-2
23
2
-41
2
34
-50
3
-9
22
Financing Cash Flow
52
1
2
49
1
49
2
0
5
49
Change in Cash
14
5
5
17
-34
59
-47
25
-36
65

Ardelyx Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-64
-91
-94
-94
-158
-67
-66
-39
-61
Operating Cash Flow
-65
-70
-76
-81
-152
-70
-89
-44
-42
Investing Cash Flow
65
-29
23
-31
50
18
-131
-18
-8
Financing Cash Flow
0
103
155
22
82
75
146
106
54
Change in Cash
0
3
102
-90
-18
23
-74
43
3

Mutual Funds that own Ardelyx Stock

Check out the Mutual Funds with significant holdings in Ardelyx.

Funds
Holdings
Shares Held
Delaware Group Equity Funds V
9.033213%
22509645
VANGUARD INDEX FUNDS
4.056206%
10107563
TIAA-CREF Funds
1.990114%
4959117
VANGUARD HORIZON FUNDS
1.055333%
2629761
JANUS INVESTMENT FUND
1.041713%
2595821
See all

Global Institutional Holdings in Ardelyx

Funds
Holdings
Vanguard
5.06%
iShares
3.98%
SPDR
3.42%
Invesco
1.31%
Peter Durbin
0.75%
See all

Insights on Ardelyx

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 94.47M → 120.87M (in $), with an average increase of 21.8% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -37.60M → -16.72M (in $), with an average increase of 124.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 482.5% return, outperforming this stock by 527.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 27.1% return, outperforming this stock by 52.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, ARDX stock has moved down by -42.0%

About Ardelyx

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. Ardelyx, Inc. was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. The company was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
OrganisationArdelyx
Headquarters400 Fifth Avenue, Waltham, MA, United States, 02451
IndustryBiotechnology
CEOMr. Michael G. Raab
E-voting on sharesClick here to vote

Key Management of Ardelyx

Name

Title

Ms. Sue Hohenleitner

Chief Financial Officer

Dr. John Bishop Ph.D.

Chief Technical & Quality Officer

Dr. Laura A. Williams M.D., M.P.H.

Chief Patient Officer

Mr. Mike Kelliher

Chief Business Officer

Mr. Michael G. Raab

President, CEO & Director

Ms. Lisa M. Caperelli

Senior Vice President of Investor Relations and Corporate Communications

Ms. Felecia W. Ettenberg

Chief Legal Officer

Mr. James P. Brady

Chief Human Resources Officer

Dr. Rajani Dinavahi M.D.

Chief Medical Officer

Mr. Joseph Reilly

Senior VP of Finance & Principal Accounting Officer

FAQs

What is Ardelyx share price today?

Ardelyx share price today is $3.38 as on at the close of the market. Ardelyx share today touched a day high of $3.50 and a low of $3.34.

What is the 52 week high and 52 week low for Ardelyx share?

Ardelyx share touched a 52 week high of $8.40 on and a 52 week low of $3.34 on . Ardelyx stock price today i.e. is closed at $3.38,which is 59.76% down from its 52 week high and 1.20% up from its 52 week low.

What is Ardelyx's market capitalisation today?

Ardelyx market capitalisation is $0.00T as on .

How to invest in Ardelyx Stock (ARDX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Ardelyx on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ardelyx Shares that will get you 0.4438 shares as per Ardelyx share price of $3.38 per share as on September 18, 2026 at 1:29 am IST.

What is the minimum amount required to buy Ardelyx Stock (ARDX) from India?

Indian investors can start investing in Ardelyx (ARDX) shares with as little as ₹95.93 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.30 in Ardelyx stock (as per the Rupee-Dollar exchange rate as on ). Based on Ardelyx share’s latest price of $3.38 as on September 18, 2026 at 1:29 am IST, you will get 2.9586 shares of Ardelyx. Learn more about fractional shares .

What are the returns that Ardelyx has given to Indian investors in the last 5 years?

Ardelyx stock has given 158.78% share price returns and 29.78% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?